Hostname: page-component-8448b6f56d-dnltx Total loading time: 0 Render date: 2024-04-23T23:24:54.726Z Has data issue: false hasContentIssue false
  • English
  • Français

Acetylcysteine and lung disease

Published online by Cambridge University Press:  11 September 2013

Get access

In a nutshell

NAC is an antioxidant that stimulates GSH production. As many lung diseases involve oxidative stress, trying antioxidant treatments makes sense.

Clinical evidence supports some role for NAC in treating chronic bronchitis and COPD. Its value in other clinical situations (e.g. idiopathic lung fibrosis) is so far less clear.

Type
Brief Report
Information
Arbor Clinical Nutrition Updates , Volume 239 , February 2006 , pp. 1 - 3
Copyright
Copyright © Cambridge University Press 2006

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Dekhuijzen, PN. Antioxidant properties of N-acetylcysteine: their relevance in relation to chronic obstructive pulmonary disease. Eur Respir J. 2004 Apr;23(4):629–36.CrossRefGoogle ScholarPubMed
2. Connolly, MA. Mucolytics and the critically ill patient: help or hindrance? AACN Clin Issues. 1995 May;6(2):307–15.CrossRefGoogle ScholarPubMed
3. Duijvestijn, YC. et al. [Acetylcysteine in children with lung disorders prescribed by one-third of family physicians: no support in the literature] Ned Tijdschr Geneeskd. 1997 Apr 26;141(17):826–30.Google Scholar
4. Flanagan, RJ. et al. Use of N-acetylcysteine in clinical toxicology. Am J Med. 1991 Sep 30;91(3C):131S–139S.CrossRefGoogle ScholarPubMed
5. Holdiness, MR. Clinical pharmacokinetics of N-acetylcysteine. Clin Pharmacokinet. 1991 Feb;20(2):123–34.CrossRefGoogle ScholarPubMed
6.[Anon] N-acetylcysteine. Altern Med Rev. 2000 Oct;5(5):467–71.Google Scholar
7. http://www.lef.org/prod_hp/abstracts/php-ab059.html Google Scholar
8. MacNee, W. Pulmonary and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2005;2(1):50–60.CrossRefGoogle ScholarPubMed
9. Sadowska, AM. et al. The interrelationship between markers of inflammation and oxidative stress in chronic obstructive pulmonary disease: modulation by inhaled steroids and antioxidant. Respir Med. 2005 Feb;99(2):241–9.CrossRefGoogle Scholar
10. Kinnula, VL. Focus on antioxidant enzymes and antioxidant strategies in smoking related airway diseases. Thorax. 2005 Aug;60(8):693–700.CrossRefGoogle ScholarPubMed
11. Bernard, GR. N-acetylcysteine in experimental and clinical acute lung injury. Am J Med. 1991 Sep 30;91(3C):54S–59S.CrossRefGoogle ScholarPubMed
12. Kinnula, VL. et al. Oxidative stress in pulmonary fibrosis: a possible role for redox modulatory therapy. Am J Respir Crit Care Med. 2005 Aug 15;172(4):417–22.CrossRefGoogle ScholarPubMed
13. Stey, C. et al. The effect of oral N-acetylcysteine in chronic bronchitis: a quantitative systematic review. Eur Respir J. 2000 Aug;16(2):253–62.CrossRefGoogle ScholarPubMed
14. Grandjean, EM. et al. Efficacy of oral long-term N-acetylcysteine in chronic bronchopulmonary disease: a meta-analysis of published double-blind, placebo-controlled clinical trials. Clin Ther. 2000 Feb;22(2):209–21.CrossRefGoogle ScholarPubMed
15. Hansen, NC. et al. Orally administered N-acetylcysteine may improve general well-being in patients with mild chronic bronchitis. Respir Med. 1994 Aug;88(7):531–5.CrossRefGoogle ScholarPubMed
16. Rasmussen, JB. et al. Reduction in days of illness after long-term treatment with N-acetylcysteine controlled-release tablets in patients with chronic bronchitis. Eur Respir J. 1988 Apr;1(4):351–5.CrossRefGoogle ScholarPubMed
17. Pela, R. et al. N-acetylcysteine reduces the exacerbation rate in patients with moderate to severe COPD. Respiration. 1999 Nov-Dec;66(6):495–500.CrossRefGoogle ScholarPubMed
18. Reichenberger, F. et al. [N-acetylcystein in the therapy of chronic bronchitis] Pneumologie. 2002 Dec;56(12):793–7.CrossRefGoogle Scholar
19. Gerrits, CM. et al. N-acetylcysteine reduces the risk of re-hospitalisation among patients with chronic obstructive pulmonary disease. Eur Respir J. 2003 May;21(5):795–8.CrossRefGoogle ScholarPubMed
20. Lukas, R. et al. [Antioxidant treatment with N-acetylcysteine and vitamin C in patients with chronic bronchitis] Dtsch Med Wochenschr. 2005 Mar 18;130(11):563–7.CrossRefGoogle Scholar
21.[Anon] Oral N-acetylcysteine and exacerbation rates in patients with chronic bronchitis and severe airways obstruction. British Thoracic Society Research Committee. Thorax. 1985 Nov;40(11):832–5.Google Scholar
22. Duijvestijn, YC. et al. Systematic review of N-acetylcysteine in cystic fibrosis. Acta Paediatr. 1999 Jan;88(1):38–41.CrossRefGoogle ScholarPubMed
23. Angdin, M. et al. Protective effect of antioxidants on pulmonary endothelial function after cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 2003 Jun;17(3):314–20.CrossRefGoogle ScholarPubMed
24. Bylin, G. et al. No influence of acetylcysteine on gas exchange and spirometry in chronic asthma. Eur J Respir Dis. 1987 Aug;71(2):102–7.Google ScholarPubMed
25. Suter, PM. et al. N-acetylcysteine enhances recovery from acute lung injury in man. A randomized, double-blind, placebo-controlled clinical study. Chest. 1994 Jan;105(1):190–4.CrossRefGoogle Scholar
26. Domenighetti, G. et al. Treatment with N-acetylcysteine during acute respiratory distress syndrome: a randomized, double-blind, placebo-controlled clinical study. J Crit Care. 1997 Dec;12(4):177–82.CrossRefGoogle ScholarPubMed
27. Adhikari, N. et al. Pharmacologic therapies for adults with acute lung injury and acute respiratory distress syndrome. Cochrane Database Syst Rev. 2004 Oct 18;(4):CD004477.Google Scholar
28. De Flora, S. et al. Attenuation of influenza-like symptomatology and improvement of cell-mediated immunity with long-term N-acetylcysteine treatment. Eur Respir J. 1997 Jul;10(7):1535–41.CrossRefGoogle ScholarPubMed
29. Bailey, B. et al. Management of anaphylactoid reactions to intravenous N-acetylcysteine. Ann Emerg Med. 1998 Jun;31(6):710–5.CrossRefGoogle ScholarPubMed
30. Szkudlarek, U. et al. Effect of inhaled N-acetylcysteine on hydrogen peroxide exhalation in healthy subjects. Pulm Pharmacol Ther. 2004;17(3):155–62.CrossRefGoogle ScholarPubMed